Evaluation of validity, reliability and ability to detect change for the Hand Eczema Severity Index (HECSI) and evaluation of HECSI‐75 and HECSI‐90 as within‐patient responder definitions

Yasemin Topal Yüksel,Henrik Thoning,Lotte Seiding Larsen,Lucine Lehmann,Rob Arbuckle,Laura Grant,Tove Agner
DOI: https://doi.org/10.1111/cod.14699
2024-10-14
Contact Dermatitis
Abstract:The Hand Eczema Severity Index (HECSI) is a Clinician‐Reported Outcome measure designed to assess the intensity and extent of six clinical hand eczema signs in five areas of the hand. Data from a clinical trial evaluating the efficacy of delgocitinib cream for treatment of Chronic Hand Eczema (CHE) were used to explore the psychometric properties of the HECSI and the appropriateness of the HECSI‐75 and HECSI‐90 as clinically meaningful within‐patient responder definitions. Results provide evidence that the HECSI is valid, reliable and sensitive to change in the context of use of CHE clinical trials and that the HECSI‐75 and HECSI‐90 are appropriate for defining clinically meaningful change. Background The Hand Eczema Severity Index (HECSI) is a Clinician‐Reported Outcome measure of the severity of hand eczema (HE). Objectives This study aimed to evaluate the validity, reliability and ability to detect change of the HECSI, and the HECSI‐75 and HECSI‐90 as responder definitions. Methods Analyses were performed using data from a sample of n = 258 patients with Chronic Hand Eczema (CHE) from a Phase 2b, randomised, double‐blind, vehicle‐controlled trial of delgocitinib cream, pooled across treatment groups. The measurement properties of the HECSI were assessed and the adequacy of the HECSI‐75 and HECSI‐90 as responder definitions was explored through cross‐tabulation. Results Inter‐item correlations provided support for the scoring, whereby items are grouped by areas of the hand. HECSI demonstrated good test–retest reliability with intra‐class correlations >0.70. Construct validity was supported by a logical pattern of correlations with concurrent measures and significant differences in HECSI scores across severity groups (p
dermatology,allergy
What problem does this paper attempt to address?